Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Lonicera periclymenum
Fragrant European climbing honeysuckle used in folk medicine for respiratory, antimicrobial, and skin conditions.
Lonicera periclymenum (European honeysuckle) is a fragrant climbing plant traditionally used in European folk medicine for respiratory conditions, sore throats, and skin inflammations. Its key active compounds include luteolin, chlorogenic acid, quercetin, and saponins, which contribute to its antiviral, expectorant, and anti-inflammatory properties. Evidence is limited to traditional use and preliminary studies, placing it at evidence level C.
The anti-inflammatory and antiviral effects are attributed to luteolin and quercetin, which inhibit NF-κB and COX-2 pathways, reducing pro-inflammatory cytokine production. Chlorogenic acid and saponins exhibit antimicrobial activity by disrupting bacterial cell membranes and inhibiting viral replication. The expectorant action likely stems from saponins stimulating bronchial secretions and mucociliary clearance. These mechanisms are supported by in vitro and limited in vivo studies.
Fragrant European climbing honeysuckle used in folk medicine for respiratory, antimicrobial, and skin conditions.
Lonicera periclymenum (European honeysuckle) is a fragrant climbing plant traditionally used in European folk medicine for respiratory conditions, sore throats, and skin inflammations. Its key active compounds include luteolin, chlorogenic acid, quercetin, and saponins, which contribute to its antiviral, expectorant, and anti-inflammatory properties. Evidence is limited to traditional use and preliminary studies, placing it at evidence level C.
The anti-inflammatory and antiviral effects are attributed to luteolin and quercetin, which inhibit NF-κB and COX-2 pathways, reducing pro-inflammatory cytokine production. Chlorogenic acid and saponins exhibit antimicrobial activity by disrupting bacterial cell membranes and inhibiting viral replication. The expectorant action likely stems from saponins stimulating bronchial secretions and mucociliary clearance. These mechanisms are supported by in vitro and limited in vivo studies.